Taking people in FranceNo phase
Follow-up of Patients With Inflammatory Myopathies Associated With a Biobank
Key facts
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Where
- Paris, FranceSee the 2 sites
- Trial code
- Status
- Recruiting
- People taking part
- 4,000 people, planned
- Started
- 26 Oct 2022
- Expected to end
- 26 Oct 2057
- Type of study
- Observational
- Record updated
- 23 April 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Age ≥ 18 years
- Suspicion of Myositis defined according to reference classifications: Dermatomyositis (DM), polymyositis (PM) defined as early as 1975 by Bohan and Peter, inclusion myositis (IM) according to the criteria of Griggs et al, 1995 and autoimmune necrotizing myopathy (ANM) by Hoogendijk et al, in 2004 and iatrogenic (e.g. drug-induced) myositis
- No opposition from patients to the use of their data
- Signature of consents for the constitution of the biobank and the genetic analyses
Who cannot take part
- Patients under AME
- Patients under legal protection
Where in France
- Département de médecine interne et immunolgie clinique, Hôpital Pitié SalpêtrièreParis, FranceContact: Olivier BENVENISTE, MD, PhDTaking people
- Département de pharmacologie clinique, Hôpital Pitié SalpêtrièreParis, FranceContact: Joe-Elie SALEM, MD, PhDTaking people
About the trial
What the trial wants to find out
Myositis are rare diseases for which the development of a cohort associated with a bank of biological samples (biobank) will allow for the conduct of researches to better delineate the underlying pathophysiology and find cures. This prospective cohort of patients with myositis will allow for identification of factors favouring the occurrence of myositis, whether they are constitutional (genetic) or acquired (environmental or drug). Different subgroups of myositis used for prognostication will be identified based on clinico-demographical variables, the nature of the organs involved beyond peripheral muscles (cardiac, diaphragm) and biomarkers abnormalities
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Follow-up of a Cohort of Patients With Inflammatory Myopathies Associated With a Biobank: MASC 2 Project (Myositis, Muscles, DNA/RNA Serum Cells)
- Record updated
- 23 April 2025